written on 03.06.2014

Novartis names Merck exec Bruno Strigini oncology chief


Most recently Mr Strigini was president for Europe/Canada at Merck and Co, which is known as MSD outside of the US and Canada. He joined MSD as part of the 2009 $41bn merger with Schering-Plough. At Schering-Plough, he was president of EUCAN II (a…